← Back to Search

Behavioral Intervention

PEER-CM for Methamphetamine Abuse

N/A

Recruiting

Research Sponsored by Oregon Health and Science University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months from baseline

Awards & highlights

Study Summary

This trial aims to compare two approaches to helping people reduce harm from methamphetamine use. One approach involves rewarding individuals for achieving their own harm reduction goals, while the other involves providing peer support with incentives for

Who is the study for?

This trial is for community-based organizations that use peer support to help individuals with methamphetamine abuse. These organizations should be open to training in two strategies for peer-facilitated harm reduction and contingency management.Check my eligibility

What is being tested?

The study compares two methods: one where clients are incentivized to achieve personal harm reduction goals (Contingency Management), and the standard of care which includes incentives for visiting peers who provide harm reduction services.See study design

What are the potential side effects?

Since this trial involves organizational interventions rather than medical treatments, it does not have traditional side effects. However, there may be impacts on service delivery or client engagement that will be monitored.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months from baseline

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months from baseline

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months from baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of participants who achieve self-identified goals

Number of participants who engage in substance use disorder treatment

Number of participants who overdose

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: PEER-CMExperimental Treatment1 Intervention

Peer-facilitated contingency management (PEER-CM).

Group II: Standard of CareActive Control1 Intervention

Standard of care contingency management.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor

974 Previous Clinical Trials

7,384,112 Total Patients Enrolled

2 Trials studying Methamphetamine Abuse

126 Patients Enrolled for Methamphetamine Abuse

Comagine HealthUNKNOWN

2 Previous Clinical Trials

653 Total Patients Enrolled

Oregon Health AuthorityUNKNOWN

3 Previous Clinical Trials

22,418 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for patient participation in this clinical trial?

"Indeed, as per clinicaltrials.gov, this ongoing study is actively seeking eligible participants. Originally shared on November 13th, 2023, the trial's most recent update was made on March 25th, 2024. Recruitment aims to enroll a total of 1800 patients from two designated sites."

Answered by AI

Is the clinical trial accepting individuals aged 70 and above as participants?

"The trial is seeking individuals over 18 years of age but under the age of 105."

Answered by AI

What is the total number of participants involved in this clinical research study?

"Indeed, data from clinicaltrials.gov highlights that this particular medical investigation is actively seeking eligible individuals. The trial was initially made public on November 13th, 2023 and underwent its most recent revision on March 25th, 2024. This study aims to enroll a total of 1800 participants across two designated sites."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)

P. Todd Korthuis, MD 2023. "Peer Engagement in Methamphetamine Harm-Reduction With Contingency Management (PEER-CM)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05700994.